WAS
AGN

WESPAC Advisors SoCal’s Allergan plc AGN Stock Holding History

WESPAC Advisors SoCal’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,470
Closed -$506K – 294
2017
Q3 		$506K Sell
2,470
-5
-0.2% -$1.16K 0.3% 57
2017
Q2 		$601K Buy
2,475
+38
+2% +$8.93K 0.38% 43
2017
Q1 		$582K Buy
2,437
+325
+15% +$75.7K 0.36% 43
2016
Q4 		$444K Sell
2,112
-318
-13% -$65.9K 0.29% 52
2016
Q3 		$560K Buy
2,430
+68
+3% +$16.6K 0.38% 46
2016
Q2 		$546K Buy
2,362
+2,307
+4,195% +$532K 0.36% 45
2016
Q1 		$14.7K Buy
+55
New +$15.7K 0.01% 174

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

WESPAC Advisors SoCal's AGN Position: Q4 2017 in Review

WESPAC Advisors SoCal sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 2,470 shares — an estimated $506K sold.

WESPAC Advisors SoCal first reported a position in AGN in Q1 2016 and held it in 7 quarters. The position peaked at $601K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • WESPAC Advisors SoCal reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 2,470 Allergan plc shares in Q4 2017, an estimated $506K.
  • WESPAC Advisors SoCal first reported a position in Allergan plc in Q1 2016 and held it in 7 quarters.
  • WESPAC Advisors SoCal's Allergan plc position peaked at $601K in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on WESPAC Advisors SoCal's 13F filing for Q4 2017, filed 13 Feb 2018.